IsoRay (ISR) Receives a Buy from H.C. Wainwright


H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on IsoRay (ISR) today and set a price target of $0.70. The company’s shares opened today at $0.43.

Ramakanth said:

“We derive a 12-month price target of $0.70 per share based on an NPV analysis of projected product revenues through FY2030. We assume a 12.7% discount rate, formulated by our calculation of IsoRay’s weighted average cost of capital, and 3% terminal growth rate.”

According to TipRanks.com, Ramakanth has currently no stars on a ranking scale of 0-5 stars, with an average return of -2.8% and a 35.5% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals Inc, Collplant Holdings Ltd, and Trillium Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for IsoRay with a $0.70 average price target.

See today’s analyst top recommended stocks >>

Based on IsoRay’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $1.51 million. In comparison, last year the company had a GAAP net loss of $1.46 million.

Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ISR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts